Login | Register

Januvia (Sitagliptin) Approved For Those With Type 2 Diabetes With Renal Impairment, UK

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Januvia (sitagliptin) in the UK for use in individuals suffering from moderate to severe renal impairment. As a result, another treatment will be available for individuals with sub-optimum kidney function, who represent up to one third of all those with diabetes...

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *